ZA963478B - Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation - Google Patents

Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Info

Publication number
ZA963478B
ZA963478B ZA963478A ZA963478A ZA963478B ZA 963478 B ZA963478 B ZA 963478B ZA 963478 A ZA963478 A ZA 963478A ZA 963478 A ZA963478 A ZA 963478A ZA 963478 B ZA963478 B ZA 963478B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical composition
composition containing
tiagabine hydrochloride
containing tiagabine
Prior art date
Application number
ZA963478A
Other languages
English (en)
Inventor
Jorgen Ryhl Svensson
Lars Nygaard
Tina Meinertz Andersen
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA963478B publication Critical patent/ZA963478B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA963478A 1995-05-05 1996-05-02 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation ZA963478B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05

Publications (1)

Publication Number Publication Date
ZA963478B true ZA963478B (en) 1996-11-13

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963478A ZA963478B (en) 1995-05-05 1996-05-02 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Country Status (26)

Country Link
US (1) US5866590A (xx)
EP (1) EP0830132B1 (xx)
JP (1) JP3195360B2 (xx)
KR (1) KR100440354B1 (xx)
CN (1) CN1092959C (xx)
AR (1) AR003418A1 (xx)
AT (1) ATE211911T1 (xx)
AU (1) AU707508B2 (xx)
BR (1) BR9608120A (xx)
CA (1) CA2220019C (xx)
CZ (1) CZ292256B6 (xx)
DE (1) DE69618586T2 (xx)
DK (1) DK0830132T3 (xx)
EG (1) EG23781A (xx)
ES (1) ES2171669T3 (xx)
HU (1) HU223075B1 (xx)
IL (1) IL118142A (xx)
MX (1) MX9708394A (xx)
MY (1) MY115016A (xx)
NO (1) NO318599B1 (xx)
NZ (1) NZ307159A (xx)
PL (1) PL183678B1 (xx)
PT (1) PT830132E (xx)
UA (1) UA43402C2 (xx)
WO (1) WO1996034606A1 (xx)
ZA (1) ZA963478B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
EP0991409B1 (en) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Controlled release pharmaceutical compositions containing tiagabine
WO1999017771A1 (en) * 1997-10-02 1999-04-15 H. Lundbeck A/S Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
JP2004506609A (ja) * 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
JP2015526385A (ja) * 2012-05-08 2015-09-10 セリックスビオ プライヴェート リミテッド てんかんの治療のための組成物及び方法
EP3342410A4 (en) * 2015-08-28 2019-04-24 Nippon Kayaku Kabushiki Kaisha PHARMACEUTICAL COMPOSITION WITH RAPAMYCIN OR DERIVATIVES THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
CN1183721A (zh) 1998-06-03
AR003418A1 (es) 1998-08-05
MY115016A (en) 2003-03-31
EG23781A (en) 2007-08-13
HUP9802741A2 (hu) 1999-03-29
IL118142A (en) 1999-11-30
CZ292256B6 (cs) 2003-08-13
JP3195360B2 (ja) 2001-08-06
MX9708394A (es) 1998-02-28
AU5644196A (en) 1996-11-21
KR100440354B1 (ko) 2004-09-18
JPH10505359A (ja) 1998-05-26
UA43402C2 (uk) 2001-12-17
HUP9802741A3 (en) 1999-04-28
PT830132E (pt) 2002-07-31
ES2171669T3 (es) 2002-09-16
IL118142A0 (en) 1996-09-12
ATE211911T1 (de) 2002-02-15
CA2220019C (en) 2007-12-11
AU707508B2 (en) 1999-07-15
BR9608120A (pt) 1999-02-09
CN1092959C (zh) 2002-10-23
EP0830132A1 (en) 1998-03-25
DE69618586D1 (de) 2002-02-21
PL183678B1 (pl) 2002-06-28
PL323138A1 (en) 1998-03-16
NZ307159A (en) 1998-10-28
HU223075B1 (hu) 2004-03-01
DK0830132T3 (da) 2002-04-29
WO1996034606A1 (en) 1996-11-07
CZ338897A3 (cs) 1998-03-18
CA2220019A1 (en) 1996-11-07
US5866590A (en) 1999-02-02
NO975076L (no) 1997-11-04
NO975076D0 (no) 1997-11-04
DE69618586T2 (de) 2002-09-05
EP0830132B1 (en) 2002-01-16
NO318599B1 (no) 2005-04-18

Similar Documents

Publication Publication Date Title
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUP9602122A3 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HU9601698D0 (en) Pharmaceutical composition
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
ZA961051B (en) Pharmaceutical composition
ZA9610426B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
IL115981A (en) Cyclolignan derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9900079A3 (en) 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP9600061A2 (en) 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same
HUP9602822A2 (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone
HU9500156D0 (en) Pharmaceutical composition and process
IL117302A0 (en) Cryptophycin derivatives methods for the production thereof and pharmaceutical compositions containing the same